𝔖 Bobbio Scriptorium

✦ LIBER ✦

52 Radioimmunotherapy of glioblastoma by means of131I-Labeled monoclonal antibodies intralesionally injected: A phase I and phase II investigation

✍ Scribed by Franceschi, G.; Arista, A.; Sturiale, C.; Riva, N.; Casi, M.; Visani, L.; Cremonini, A.M.; Riva, P.

Book ID: 123063826
Publisher: Elsevier Science
Year: 1996
Tongue: English
Weight: 155 KB
Volume: 39
Category: Article
ISSN: 0167-8140
DOI: 10.1016/0167-8140(96)87853-4

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Tandem high-dose therapy in relapsed and

Tandem high-dose therapy in relapsed and refractory B-cell lymphoma: results of a prospective phase II trial of myeloablative chemotherapy, followed by escalated radioimmunotherapy with131I-anti-CD20 antibody and stem cell rescue

✍ Karin Hohloch; Carsten Oliver Sahlmann; Vijai J. Lakhani; Gerald Wulf; Bertram G 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 233 KB

609 A Phase 1 Study of MEDI-573, an Inve

609 A Phase 1 Study of MEDI-573, an Investigational Monoclonal Antibody That Targets IGF-I and IGF-II: Safety, Pharmacokinetics, and Antitumor Activity in Adults with Advanced Solid Tumors

✍ Haluska, P.; Menefee, M.E.; Plimack, E.R.; Rosenberg, J.E.; Northfelt, D.W.; LaV 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 79 KB

Immunotherapy with FBTA05 (Bi20), a trif

Immunotherapy with FBTA05 (Bi20), a trifunctional bispecific anti-CD3 x anti-CD20 antibody and donor lymphocyte infusion (DLI) in relapsed or refractory B-cell lymphoma after allogeneic stem cell transplantation: study protocol of an investigator-driven, open-label, non-randomized, uncontrolled, dose-escalating Phase I/II-trial

✍ Raymund Buhmann, Stanglmaier Michael, Hess Juergen… 📂 Article 📅 2013 🏛 BioMed Central 🌐 English ⚖ 328 KB

86 A phase I/II open-label study to asse

86 A phase I/II open-label study to assess the safety, pharmacokinetic profile, and preliminary antiviral effects of ost-577 (a human anti-hepatitis b surface antigen monoclonal antibody) administered to patients who are persistently hepatitis b antigen seropositive: DP Paar, MD, BM Montgomerie, RN, P Nadler, MD, ER Schiff, MD and RB Pollard, MD. The University of Texas Medical Branch at Galveston, Galveston, TX, USA; Protein Design Labs, Mountain View, CA, USA; the University of Miami, Miami, FL, USA

📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 76 KB